|
|
| (3 intermediate revisions by the same user not shown) |
| Line 1: |
Line 1: |
| | + | {{frontpage |
| | + | |pagetitle =Autoimmune Diseases |
| | + | |pagebody = |
| | + | |contenttitle =Content |
| | + | |contentbody =<big><b> |
| | + | <categorytree mode=pages>Autoimmune Diseases</categorytree> |
| | | | |
| | + | </b></big> |
| | + | |logo =path-logo.png |
| | + | }} |
| | | | |
| − | ==Antibody mediated autoimmune diseases==
| |
| − | [[Image:ImageNeeded.png|right|thumb|150px|Myasthenia gravis]]
| |
| | | | |
| − | ===1. Immune Mediated Haemolytic Anaemia (IMHA)===
| + | [[Category:Immunological Disorders]] |
| − | | |
| − | '''Pathogenesis:''' [[Type II Hypersensitivity - WikiBlood|Type II hypersensitivity]]
| |
| − | | |
| − | * Autoantibody attack on the red blood cells causing extravascular and intravascular lysis which causes anaemia.
| |
| − | * The in saline autoagglutination test and the coombes test is used to diagnose the disorder.
| |
| − | | |
| − | ===2. Immune Mediated Thrombocytopaenia (IMTP) ===
| |
| − | | |
| − | '''Pathogenesis:''' [[Type II Hypersensitivity - WikiBlood|Type II hypersensitivity]]
| |
| − | | |
| − | * There is an immunological attack on the platelets which reduces the ability for clotting.
| |
| − | * A reduced platelet count and detection of anti-platelet antibodies in the serum are used for diagnosis of this disorder.
| |
| − | | |
| − | ===3. Myasthenia gravis===
| |
| − | | |
| − | '''Pathogenesis:''' [[Type II Hypersensitivity - WikiBlood|Type II hypersensitivity]]
| |
| − | | |
| − | ===4. Bullous Pemphigoid===
| |
| − | | |
| − | '''Pathogenesis:''' [[Type II Hypersensitivity - WikiBlood|Type II hypersensitivity]]
| |
| − | | |
| − | ===5. Pemphigus Vulgaris===
| |
| − | | |
| − | '''Pathogenesis:''' [[Type II Hypersensitivity - WikiBlood|Type II hypersensitivity]]
| |
| − | | |
| − | ===6. Systemic Lupus Erythematosus (SLE)/Multi-systemic immune mediated disease===
| |
| − | | |
| − | '''Pathogenesis:''' [[Type III Hypersensitivity - WikiBlood|Type III hypersensitivity]]
| |
| − | | |
| − | ==Cell mediated autoimmune diseases==
| |
| − | [[Image:Rheumatoid Arthritis Type IV hypersensitivity.jpg|right|thumb|150px|Rheumatoid Arthritis-Brian Catchpole RVC 2008]]
| |
| − | [[Image:Diabetes Mellitus Type IV hypersensitivity.jpg|right|thumb|150px|Diabetes Mellitus-Brian Catchpole RVC 2008]]
| |
| − | | |
| − | ===1. Rheumatoid arthritis===
| |
| − | | |
| − | '''Pathogenesis:'''
| |
| − | | |
| − | * [[Type IV Hypersensitivity - WikiBlood|Type IV hypersensitivity]]: CD4 Th-1 cell mediated.
| |
| − | * Macrophages phagocytose self antigens and can present peptides on their MHC Class II molecules. The autoreactive TH-1 cells release IFN-gamma which activates macrophages to release prostaglandins, MMP enzymes and TNF-alpha (pro-inflammatory mediator), see diagram. These cytokines cause inflammation and tissue destruction.
| |
| − | | |
| − | ===2. Diabetes Mellitus type I===
| |
| − | '''Pathogenesis:'''
| |
| − | | |
| − | * [[Type IV Hypersensitivity - WikiBlood|Type IV hypersensitivity]]
| |
| − | * The CTLs think that all the beta cells in the pancreas are infected by a virus, as it wrongly detects a self antigen presented by the MHC class I on the surface of the cell as foreign.
| |
| − | * Autoreactive CD8+ CTLs are inadvertently activated, destroying the beta cells, thus preventing the secretion of insulin and causing diabetes type 1 (see diagram).
| |
| − | | |
| − | ===3. Hypothyroidism (lymphocytic throiditis)===
| |
| − | | |
| − | '''Pathogenesis:''' [[Type IV Hypersensitivity - WikiBlood|Type IV hypersensitivity]]
| |
| − | | |
| − | * T cell mediated
| |
| − | | |
| − | ===4. Hypoadrenocorticism (Addisons disease)===
| |
| − | | |
| − | '''Pathogenesis:''' [[Type IV Hypersensitivity - WikiBlood|Type IV hypersensitivity]]
| |
| − | | |
| − | [[Category:Lymphoreticular and Haemopoietic Diseases]]
| |
| − | [[Category:Immunology]] | |
